Skip to main content

Table 3 Correlation between plasma Lp-PLA2 and (1) CSF biomarkers for AD and (2) Schelten Score for white matter changes

From: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

 

-ß- amyloid(1-42)

P-Tau (181P epitope)

T-Tau

Schelten Score

 

r ( P )

r ( P )

r ( P )

r ( P )

AD ( n = 78)

-0.01 (0.91)

-0.20 (0.08)

-0.10 (0.40)

-0.03 (0.82)

aMCI ( n = 59)

-0.29 (0.03)

-0.08 (0.54)

-0.14 (0.28)

0.20 (0.12)

Normal controls

( n = 28 (CSF tests); n = 66 (Scheltens))

-0.17 (0.39)

0.35 (0.07)

0.27 (0.16)

-0.06 (0.63)

  1. Correlations with P- value < 0.05 are presented in bold.